Progress and prospects: immune responses to viral vectors

Area of Science:

• Immunology
• Gene Therapy
• Molecular Biology

Background:

• Viral vectors are key for gene delivery but trigger immune responses.
• Innate and adaptive immunity can limit the efficacy of in vivo gene transfer.
• Preexisting immunity and responses to transgene products complicate vector use.

Purpose of the Study:

• To review immune system interactions with common viral vectors.
• To summarize current knowledge on immune responses to gene therapy vectors.
• To highlight strategies for overcoming immune barriers in gene therapy.

Main Methods:

• Review of current literature on viral vector immunology.
• Analysis of immune responses against adeno-associated virus, adenoviral, and lentiviral vectors.
• Examination of strategies to mitigate immune reactions.

Main Results:

• Immune responses against vector antigens and transgene products reduce gene transfer efficacy.
• Preexisting antibodies and memory responses pose challenges for vector administration.
• Engineered vectors and novel strategies aim to suppress or evade immune detection.

Conclusions:

• Understanding immune interactions is crucial for effective gene therapy.
• Developing immune-tolerant vectors is essential for sustained therapeutic effects.
• Future strategies focus on manipulating immune responses for successful gene transfer.